EP3122426
Meðhöndlun á brjóstakrabbameini með því að nota valvísa estrógenviðtakastilla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.3.2015EP published:
18.1.2023EP application number:
15769394.6
EP translation filed:
20.3.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
27.3.2035Expiry date:
27.3.2027Next due date:
31.3.2027
Title in English:
TREATING BREAST CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORSLanguage of the patent:
English
Timeline
Today
28.3.2015EP application
18.1.2023EP Publication
20.3.2023Translation submitted
15.4.2023Registration published
27.3.2027Expires
Owner
Name:
Duke UniversityAddress:
2812 Erwin Road, Suite 306, Durham, NC 27705, US
Inventor
Name:
WARDELL, Suzanne, E.Address:
Durham, NC 27712, US
Name:
NELSON, Erik, R.Address:
Champaign, IL 61822, US
Name:
MCDONNELL, Donald, P.Address:
Chapel Hill, NC 27516, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461971627 PDate:
28.3.2014Country:
US
Number:
201414512061Date:
10.10.2014Country:
US
Number:
201562129379 PDate:
6.3.2015Country:
US
Supplementary protection
SPC number:
SPC455
Classification
Categories:
A61K 31/137, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.3.2023
Expires: 27.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 6.3.2024
Expires: 27.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.2.2025
Expires: 27.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 27.3.2026
Expires: 27.3.2027
Payer: Árnason Faktor ehf.